Clinical trials recruiting for Head and neck cancer
62
Recruiting trials
36
US states with sites
21
Countries
8%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Carboplatin | 2 |
| Docetaxel | 2 |
| Pembrolizumab | 2 |
| Riluzole | 2 |
| 5Fluorouracil | 1 |
| AB122 | 1 |
| AB154 | 1 |
| Adoptive therapy with autologous MC2 TCR T cells | 1 |
| Atezolizumab | 1 |
| Bevacizumab | 1 |
| Brodalumab | 1 |
| Carboplatin (AUC 5) | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 13 |
| Texas | 13 |
| Florida | 10 |
| New York | 10 |
| Tennessee | 8 |
| Massachusetts | 6 |
| Pennsylvania | 6 |
| Colorado | 5 |
| Missouri | 5 |
| New Jersey | 5 |
| Ohio | 5 |
| Maryland | 4 |
Top cities
Houston, Texas 8Nashville, Tennessee 8New York, New York 7Boston, Massachusetts 6Miami, Florida 6Duarte, California 5Pittsburgh, Pennsylvania 5San Antonio, Texas 5St Louis, Missouri 5Los Angeles, California 4
Self-screener
Recruiting trials
- 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
- A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
- A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
- A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- A Study of a New PET Scanner in People With Cancer
- A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies
- AB122 Platform Study
- ATATcH Alternating Treatment Plans for Advanced Cancer
- Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- Brodalumab in the Treatment of Immune-Related Adverse Events
- Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
- Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
- DESTINY-PANTUMOUR04
- Deciphering Mechanisms Underlying Cancer Immunogenicity
- Distance-Based Exercise to Preserve Function and Prevent Disability
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- EXCEL: Exercise for Cancer to Enhance Living Well
- Ex VIvo DEtermiNed Cancer Therapy
- Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)
- Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac
- GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
- High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins
- Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer
- Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
- Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
- Improving Care for Rural Patients With Solid Tumors
- Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
- Jump: MR Simulation For Radiation Therapy Master Protocol
- LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
- Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Liquid Biopsy Evaluation and Repository Development at Princess Margaret
- Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)
- MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer
- MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
- MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy)
- Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
- Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)
- Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
- Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
- Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
- PromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors
- Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
- RAPA-201 Therapy of Solid Tumors
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
- Sample Collection for Ongoing Research and Product Evaluation Study
- Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
- Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)
- Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
- Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.
- Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
- Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
- Trop2-targeted immunoPET Imaging of Solid Tumors
- Ultrasound Spectroscopy as Early Indicators of Radiation Treatment Response in Prostate, Rectum and Head & Neck Cancers
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Related conditions
Trials recruiting for Head and neck cancer often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Breast cancer 2239Colorectal cancer 1359Prostate cancer 1234Melanoma 487Pancreatic cancer 870Esophageal cancer 65Ovarian cancer 118Sarcoma 48Liver cancer 43
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Head and neck cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.